Consequent pharmacological inhibition of the ATM pathway restored the tumor’s radiosensitivity, suggesting the translational potential to improve radiotherapy outcomes for patients with IDH1 gliomas harboring similar mutations. This evidence concerns the gene ATM and central nervous system cancer.